Tetraphase announces receipt of amended melinta proposal, determination of superior offer and notice to acelrx

Tetraphase announces receipt of amended melinta proposal, determination of superior offer and notice to acelrx.tetraphase pharmaceuticals - under amended melinta proposal, melinta has offered to acquire co for $39.0 million in cash, plus an additional $16.0 million.tetraphase pharma - if amended melinta proposal continues to be a superior offer through june 3, co will consider terminating acelrx merger agreement.tetraphase pharmaceuticals inc - at this time, board has not changed its recommendation with respect to pending transaction with acelrx.tetraphase pharma- given notice to acelrx of intention to consider changing recommendation/terminating deal agreement unless acelrx proposes revisions.
ACRX Ratings Summary
ACRX Quant Ranking